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Article
Human RIF1 and protein phosphatase 1 stimulate
DNA replication origin licensing but suppress
origin activation
Shin-ichiro Hiraga1,* , Tony Ly2, Javier Garzón1, Zuzana Horejsí3,†, Yoshi-nobu Ohkubo4, Akinori
Endo2,‡, Chikashi Obuse4, Simon J Boulton3, Angus I Lamond2 & Anne D Donaldson1,**
Abstract
The human RIF1 protein controls DNA replication, but the molecu-
lar mechanism is largely unknown. Here, we demonstrate that
human RIF1 negatively regulates DNA replication by forming a
complex with protein phosphatase 1 (PP1) that limits phosphoryla-
tion-mediated activation of the MCM replicative helicase. We iden-
tify specific residues on four MCM helicase subunits that show
hyperphosphorylation upon RIF1 depletion, with the regulatory
N-terminal domain of MCM4 being particularly strongly affected.
In addition to this role in limiting origin activation, we discover an
unexpected new role for human RIF1-PP1 in mediating efficient
origin licensing. Specifically, during the G1 phase of the cell cycle,
RIF1-PP1 protects the origin-binding ORC1 protein from untimely
phosphorylation and consequent degradation by the proteasome.
Depletion of RIF1 or inhibition of PP1 destabilizes ORC1, thereby
reducing origin licensing. Consistent with reduced origin licensing,
RIF1-depleted cells exhibit increased spacing between active
origins. Human RIF1 therefore acts as a PP1-targeting subunit that
regulates DNA replication positively by stimulating the origin
licensing step, and then negatively by counteracting replication
origin activation.
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Introduction
The process of DNA replication is critical during cell proliferation
for daughter cells to inherit a complete set of genomic information.
DNA replication is therefore tightly controlled to prevent either
under- or over-replication, with the establishment of licensed DNA
replication origins and their subsequent activation closely coupled
with other cell cycle events.
Best understood in budding yeast, the mechanisms controlling
origin establishment and activation appear essentially conserved
throughout eukaryotes [1,2]. DNA replication origins are established
in G1 phase through the stepwise formation of the pre-replication
complex, composed of the origin recognition complex (ORC) and
minichromosome maintenance (MCM) hexamers [3]. ORC binds
first to potential origin sites and recruits MCM complexes, with this
“origin licensing” step assisted by Cdc6 and Cdt1 [3]. Later in the
cell cycle, origin licensing is prevented by cyclin-dependent kinase
(CDK) activity, which in human cells inhibits the loading of MCM
complex through several mechanisms [4]. One of these is cell cycle-
dependent degradation of ORC1 protein: ORC1 phosphorylation by
cyclin A–CDK2 during S/G2 cell cycle phases triggers its proteaso-
mal degradation [5,6].
Origin activation during S phase requires two protein kinase
activities, Dbf4-dependent kinase (DDK) and CDK [7]. The activ-
ities of DDK and CDK depend on cell cycle-controlled accumula-
tion of their regulatory subunits (Dbf4 and S-phase cyclins,
respectively), which are upregulated at the G1/S-phase transi-
tion. DDK phosphorylates MCM complex subunits to promote
the formation of CMG (Cdc45-MCM-GINS) complex, the active
DNA helicase at replication forks [7]. In budding yeast, phos-
phorylation sites within the N-terminal region of the Mcm4
subunit are the only essential targets for DDK to initiate DNA
replication [8]. DDK activity is proposed to be one of the limit-
ing factors for origin activation in budding yeast [9,10]. CDK in
contrast drives recruitment of DNA polymerase e, with the rele-
vant targets most clearly identified in yeast where CDK-
mediated phosphorylation of Sld2 and Sld3 promotes polymerase
loading [7].
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We and others recently discovered an additional layer of replica-
tion control in yeast, mediated by the RIF1 protein [11–13]. RIF1
was originally identified as a yeast telomeric chromatin component
[14]. The discovery that RIF1 ensures late replication of telomeres
in budding yeast [15,16] was accompanied by studies identifying a
role for RIF1 in genomewide regulation of DNA replication in
budding yeast, fission yeast, and in mammals [17–22]. In yeast
cells, the function of RIF1 in replication control is mediated by
protein phosphatase 1 (PP1) [11–13]. PP1 catalytic subunits have
poor substrate specificity and are intrinsically promiscuous, requir-
ing association with a targeting subunit for correct localization and
substrate recognition [23,24]. Yeast RIF1 acts as a PP1-targeting
subunit, interacting with PP1 and targeting it to dephosphorylate
the MCM complex. Rif1-PP1 therefore counteracts DDK to maintain
low phosphorylation levels of Mcm4, particularly during G1 phase
[11–13]. Rif1 contains a series of PP1 interaction motifs
(“[R/K]x[V/I]x[FW]” or “[S/G]IL[K/R]”) that mediate interaction
with PP1. Mutating these motifs to prevent targeting of PP1 activity
by Rif1 leads to hyperphosphorylation of Mcm4, allowing origin
activation even when DDK activity is abnormally low. The yeast
Rif1-PP1 module therefore contributes to strict cell cycle control of
MCM phosphorylation, acting as a repressor of initiation that
ensures the MCM helicase is kept inactive until cells are ready to
begin replication.
It has been unclear to what extent the function of yeast RIF1 in
regulating replication is conserved in metazoans. As in yeast,
mammalian RIF1 regulates DNA replication timing, with human and
mouse RIF1 involved in controlling the genomewide replication
program [17,19,22]. However, some effects of mammalian RIF1 do
not appear to parallel those in yeast. In particular, mouse embryonic
fibroblast cells lacking RIF1 exhibit severe sensitivity to replication-
inhibiting drugs [25], which is not the case for yeast rif1 mutants
[18,26] and is not an expected consequence of removing a replica-
tion repressor.
Mammalian cells possess three closely related subtypes of the
PP1 catalytic subunit (a, b, and c) encoded by separate genes
[23,24]. Human RIF1 does contain PP1-binding motifs, although
their position within the protein sequence differs from their arrange-
ment in yeast RIF1 [27]. Partly due to this structural divergence, it
has been unclear whether effects of mammalian RIF1 on replication
are mediated through PP1 interaction. Human and Drosophila RIF1
have been reported to interact with PP1 proteins [28–33], and based
on co-overexpression experiments, Drosophila RIF1 has been
suggested to act with PP1 during fly development [33]. However,
there has been no direct investigation either of the importance of
the PP1 motifs, or PP1 interaction, in metazoan RIF1 function.
Here, we show that the human RIF1 protein can interact with
PP1 through its PP1 interaction motifs, and that RIF1-PP1 interac-
tion is important for controlling DNA replication by limiting phos-
phorylation of the MCM complex, paralleling mechanisms in yeast.
We also discover an unexpected requirement for human RIF1-PP1
in stimulating the licensing of DNA replication origins, by ensuring
the G1-specific stabilization of ORC1 protein essential for MCM
loading on origins. Our results demonstrate that human RIF1-PP1
plays a dual role in replication control—having a repressive role at
the step of origin activation (a function that is conserved from yeast
to mammals), as well as a positive function in supporting origin
licensing that may be specific to human cells.
Results
Human RIF1 protein physically interacts with protein
phosphatase 1 via its PP1 interaction motifs
The evolutionarily conservation of PP1 interaction motifs suggests
that PP1 targeting may be a core function of eukaryotic RIF1
proteins [27]. To investigate the importance of PP1 interaction
for the function of mammalian RIF1 in DNA replication control,
we mutated the three PP1 interaction motifs of human RIF1 by
substituting critical residues with alanine (I292A, F294A, I2181A,
L2182A, V2204A, and F2206A) to create a RIF1-pp1bs allele
(Fig 1A). This RIF1-pp1bs allele and wild-type RIF1 were fused
at their N-termini to GFP as described [34]. The constructs were
integrated at the FRT site of the Flp-In T-REx 293 human cell
line, creating a set of stable cell lines with either wild-type RIF1
or RIF1-pp1bs expressed under a doxycycline-inducible promoter.
Both RIF1 and RIF1-pp1bs proteins were successfully induced by
addition of doxycycline (DOX), and localized to the nucleus
(Fig 1B). Without DOX induction, the GFP-fused proteins were
not expressed (confirmed by microscopy and Western blotting:
not shown).
We performed co-immunoprecipitation experiments to test
whether GFP-RIF1 interacts with PP1 depending on the presence of
PP1 interaction motifs. Western analysis revealed that the ectopi-
cally expressed GFP-RIF1 can physically interact with all three PP1
isoforms (Fig 1C, lane 5). In contrast, RIF1-pp1bs was unable to
interact with any PP1 isoform (lane 6), demonstrating that human
RIF1 indeed interacts with PP1 through its PP1 interaction motifs.
Only a small fraction of PP1 co-immunoprecipitated with this ectopi-
cally expressed GFP-RIF1, as expected since numerous human PP1-
interacting proteins compete for a limited pool of PP1 proteins
[28,29,35]. We could not detect PP1 in pull-down experiments
against endogenous RIF1. The amount of PP1 recovered as interact-
ing with endogenous Rif1 may simply be below our detection
threshold, or alternatively, it may be that PP1 interaction causes
masking of the RIF1 epitope recognized by the antibody we used for
pull-down. Endogenous RIF1 has however been identified in several
large-scale analyses of proteins that interact with PP1 [28,29,31,32],
confirming that the binding we observe (Fig 1C) reflects a physio-
logical interaction.
PP1 interaction is essential for human RIF1 to control
phosphorylation of MCM proteins
We next tested the importance of the RIF1-PP1 interaction in
controlling the phosphorylation of MCM proteins (Fig 2A). In these
experiments, endogenous RIF1 was depleted by siRNA [34], and
expression of either GFP, GFP-RIF1 (wild type) or GFP-RIF1-pp1bs
was induced by DOX (Fig 2A (i)). Synonymous base substitutions in
the ectopically expressed GFP-RIF1 constructs make them resistant
to siRNA targeted against endogenous RIF1 [34].
Depletion of endogenous RIF1 significantly increased the phos-
phorylation of chromatin-associated MCM4, evident from its retar-
dation on SDS–PAGE (Fig 2A (ii), lanes 2–4 and 6). Western
analysis with phospho-specific antibodies revealed increased phos-
phorylation of MCM2 at sites Ser40 and Ser53 (Fig 2A (ii), lower
two panels), residues known to be targets of DDK [36,37]. Note that
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phosphorylated MCM2 runs slightly faster in SDS–PAGE than the
unphosphorylated form [37]. The results are consistent with previ-
ous observations [19] and confirm the function of RIF1 in control-
ling the phosphorylation status of MCM proteins. Importantly,
ectopic expression of GFP-RIF1 fully suppressed the hyperphospho-
rylation of both MCM4 and MCM2 (Fig 2A (ii), lane 5), demonstrat-
ing that the ectopically expressed GFP-RIF1 fusion is functional in
controlling MCM phosphorylation. In sharp contrast, GFP-RIF1-
pp1bs was unable to suppress hyperphosphorylation of either
MCM4 or MCM2 (Fig 2A (ii), lane 7). As shown in a biological
repeat of this experiment (Fig EV1), these results are generally
reproducible although there is some variability in the apparent
extent of effects. In particular, the apparent reduction in phosphory-
lated Mcm2 Ser40 in Fig 2A (ii), lane 4 is not reproducible (Fig EV1,
lane 5). In general, these results imply that interaction of RIF1 with
PP1 is essential to prevent hyperphosphorylation of MCM4 and
MCM2.
PP1 proteins limit MCM phosphorylation
The results above strongly suggest that RIF1 directs PP1 to dephos-
phorylate MCM proteins. To confirm directly that PP1 controls
MCM phosphorylation, we tested the effect of PP1 depletion on
MCM phosphorylation. We first depleted the individual PP1
isoforms (a, b, and c) in HEK293 cells using isoform-specific siRNA
(Fig 2B (i), lanes 1–5; Appendix Fig S1). Although siRNA treatment
successfully reduced each isoform, depletion of no single isoform
caused a major change in phosphorylation of MCM4 (Fig 2B (i),
top panel, lanes 3–5; Appendix Fig S2A). The absence of changes
in MCM4 phosphorylation could reflect functional redundancy
among the PP1 isoforms. Therefore, we carried out combined
depletions of the three PP1 isoforms (Fig 2B (ii), lanes 6–11;
Appendix Fig S2B) and tested the effects on MCM4 phosphoryla-
tion. When PP1a and PP1c were depleted simultaneously, phos-
phorylation of MCM4 increased significantly (Fig 2B (ii), lane 9),
to a level close to that caused by RIF1 depletion (lane 7). Phospho-
rylation of MCM2 at Ser53 was also increased by PP1a and PP1c
double depletion. Triple depletion of PP1a, PP1b, and PP1c (lane
11) caused MCM protein hyperphosphorylation similar to that
caused by PP1a and PP1c double depletion. PP1a and PP1c may
therefore be the major isoforms that regulate MCM phosphoryla-
tion levels, with PP1b making a smaller if any contribution. Over-
all, these results demonstrate that PP1 proteins limit the
phosphorylation of MCM proteins, with PP1a and PP1c isoforms
probably playing the major role.
Taken together, the data presented imply that human RIF1 is a
PP1-targeting subunit that controls MCM helicase phosphorylation.
Figure 1. RIF1 interacts with protein phosphatase 1 isoforms.
A Construction of RIF1 cDNA mutated at its PP1 interaction motifs. Critical
residues in all three potential PP1 interaction motifs are substituted with
alanine, to create a RIF-pp1bs allele.
B Expression and localization of GFP-RIF1 fusion proteins in stably
transfected cells. Flp-In T-REx 293 cells with GFP, GFP-RIF1, or GFP-RIF1-
pp1bs were cultivated with 1 lM doxycycline (DOX) for 3 days, and
expression and localization of GFP proteins were confirmed by fluorescence
microscopy. Phase-contrast, DAPI-stain, and GFP images are shown. Scale
bar indicates 25 lm.
C RIF1 binds PP1 protein isoforms through its PP1 interaction motifs. GFP,
GFP-RIF1, and GFP-RIF1-pp1bs proteins were recovered from cell extracts
using GFP-Trap beads, and co-purifying proteins were analyzed by Western
blotting with anti-GFP (upper two panels) or isoform-specific PP1
antibodies (lower panels).
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Figure 2. RIF1 and PP1 limit MCM phosphorylation.
A (i) Outline of experiment. On Day 1, Flp-In T-REx 293 cells with integrated GFP, GFP-RIF1, or GFP-RIF1-pp1bs constructs were transfected with human RIF1 siRNA or
non-targeting control siRNA. On day 2, cells were diluted to ensure continuous cell proliferation throughout the experiment, and DOX was added to induce
transcription of GFP, or siRNA-resistant GFP-RIF1 or GFP-RIF1-pp1bs. On day 4, chromatin-enriched samples were prepared for Western blotting. (ii) GFP-RIF1
prevents hyperphosphorylation of chromatin-associated MCM proteins, while GFP-RIF1-pp1bs cannot. Upper panel confirms removal of endogenous RIF1 and
expression of GFP-RIF1 or GFP-RIF1-pp1bs. Lower three panels show Western blot analysis of chromatin-associated proteins using antibodies recognizing MCM4,
phosphorylated MCM2-S40, or phosphorylated MCM2-S53. Loading was normalized by total protein as described in Materials and Methods.
B (i) Depletion of single PP1 isoforms does not affect MCM4 phosphorylation. PP1a, PP1b, or PP1c isoforms were depleted from HEK293 cells using isoform-specific
siRNAs as indicated, and then, phosphorylation of MCM proteins was analyzed after 2 days as in (A). Depletion of PP1a, PP1b, or PP1c was confirmed (lower three
panels) by Western blotting with isoform-specific antibodies. (ii) Simultaneous depletion of PP1a and PP1c leads to hyperphosphorylation of MCM proteins. Double
and triple siRNA transfections were performed. Equal amounts of siRNAs were mixed to give a constant total siRNA concentration (50 nM), and phosphorylation
status of MCM proteins were analyzed as in (A). Loading was normalized by total protein.
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RIF1 down-regulates specific phosphosites of the MCM helicase
To explore the role of RIF1 in regulating the phosphorylation
status of MCM proteins, we performed comparative phosphopro-
teomic analysis of chromatin-associated MCM proteins from cells
depleted for RIF1 or treated with control siRNA (using asyn-
chronously growing human HEK293 cells; see Materials and
Methods for details). We identified numerous (≥ 7) phosphory-
lated serine and threonine residues within each of the MCM2,
MCM3, and MCM4 proteins (Table 1). Phosphorylation of MCM4
was the most affected by RIF1 depletion, with nine of the 14
sites identified showing substantially (> twofold) increased phos-
phorylation levels. Interestingly, the residues affected appear to be
clustered (Table 1)—in particular, all five serine and threonine
residues from positions 23 to 34 were identified as phosphorylated,
with phosphorylation levels generally four- to sixfold increased by
RIF1 depletion. A similar clustering of affected phosphorylation
sites was found at MCM4 residues 131–145 (Table 1). For MCM2,
RIF1 depletion led to substantially increased phosphorylation
levels at three of seven identified phosphorylated residues,
including serine residues at 40 and 53 consistent with the Western
analysis (Fig 2). In MCM3, however, only one (Thr728) of the 10
phosphorylation sites identified was increased upon RIF1 depletion
(Table 1).
We identified fewer phosphorylated residues within the other
three MCM subunits, with only one or two phosphorylated residues
observed for each of MCM5, MCM6, and MCM7. Among these three
proteins, only one site (MCM6 Ser762) was more than twofold
increased by RIF1 depletion, although several others were margin-
ally affected (Table 1).
For all the MCM subunits, most of the phosphorylation sites
affected by RIF1 depletion match either the CDK target consensus
sequence [S/TP] or the DDK target consensus [S or T followed by
an acidic residue, where the acidic residue may correspond to previ-
ously phosphorylated S or T] [38,39].
RIF1 interacts with PP1 and opposes DDK activity to control
replication rate
By flow cytometry analysis of cell cycle distribution, we found that
ectopic expression of GFP-RIF1 leads to an accumulation of cells in
S phase, consistent with a mild defect in DNA synthesis (Fig 3A).
The effect is likely due to excess RIF1 protein that directs PP1 to
restrict MCM phosphorylation, leading to reduced origin activation.
Supporting this explanation, ectopic expression of GFP-RIF1-pp1bs
caused little if any S-phase accumulation.
To further investigate the effect of RIF1 and its PP1 interaction
in DNA replication, we examined DNA synthesis rate in cells
ectopically expressing either GFP-RIF1 or GFP-RIF1-pp1bs. In
brief, asynchronously growing cells were pulse-labeled for 15 min
with 5-ethynyl-20-deoxyuridine (EdU), and EdU incorporation
analyzed by flow cytometry. Histograms (Fig 3B and C) show two
cell populations: cells in S phase that are incorporating significant
EdU (black plot, “EdU positive” peak), and cells at other cell
cycle stages not incorporating EdU (black plot, “EdU negative”
peak).
S-phase cells ectopically expressing GFP-RIF1 (and depleted for
endogenous RIF1) showed reduced EdU incorporation when
compared with cells without ectopic RIF1 expression (Fig 3B,
compare red plot with black and blue plots), implying a reduction
in DNA synthesis rate consistent with reduced helicase activation
due to excess RIF1. We wished to examine whether ectopic RIF1
expression interferes specifically with DDK-dependent steps of
Table 1. Changes of MCM phosphorylations caused by depleting RIF1.
Protein Position Sequencea
Changes in RIF1 siRNA
Fold changesb Log2
MCM2 26 PLTSSPG 1.30 0.38
27 LTSSPGR 0.76 0.40
40 ALTSSPG 2.04 1.03
41 LTSSPGR 1.01 0.02
53 EDESEGL 2.55 1.35
108 LTASQRE 4.43 2.15
139 LYDSDEE 0.81 0.30
MCM3 163 SDLTTLV 1.29 0.37
164 DLTTLVA 1.40 0.48
668 KKRSEDE 0.73 0.46
672 EDESETE 0.89 0.17
674 ESETEDE 0.88 0.18
708 YDPYDFS 1.24 0.31
711 YDFSDTE 1.07 0.10
713 FSDTEEE 0.92 0.12
722 QVHTPKT 1.38 0.47
728 TADSQET 2.05 1.04
MCM4 23 PAQTPRS 5.63 2.49
26 TPRSEDA 3.97 1.99
31 DARSSPS 5.60 2.48
32 ARSSPSQ 5.60 2.48
34 SSPSQRR 5.55 2.47
53 PMPTSPG 2.07 1.05
54 MPTSPGV 1.62 0.70
61 DLQSPAA 1.76 0.82
87 FDVSSPL 0.92 0.13
88 DVSSPLT 0.74 0.43
120 DLGSAQK 1.42 0.50
131 DLQSDGA 2.75 1.46
142 IVASEQS 6.10 2.61
145 SEQSLGQ 7.49 2.91
MCM5 498 WDETKGE 1.69 0.75
512 TILSRFD 1.69 0.75
MCM6 689 HADSPAP 1.22 0.29
762 EIDSEEE 5.30 2.41
MCM7 500 PRRSLEQ 1.93 0.95
aRelevant phosphorylated residue in bold text, shown in the context of its six
surrounding residues.
bChanges are standardized to overall level of each protein on chromatin.
Increases greater than twofold shown in bold.
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replication, as is the case in budding yeast [11–13]. We therefore
tested whether simultaneously limiting DDK activity exacerbates
effects of ectopic RIF1 expression, by combining ectopic RIF1
expression with addition of the DDK inhibitor XL413 [40]. XL413
treatment alone caused some reduction in EdU incorporation,
reflecting repression of cellular DNA synthesis rate due to impaired
DDK activity (Fig 3C, compare black and gray histogram profiles).
Combining RIF1 ectopic expression with XL413 treatment caused a
much more dramatic reduction in the EdU incorporation rate
(Fig 3C, red plot), considerably more severe than the effect of
either treatment alone, and indicative of substantial impairment of
DNA synthesis.
These observations are confirmed by two-dimensional plots
comparing EdU incorporation with overall DNA content, which
give more detailed analysis of cell cycle distribution within the
populations (Fig EV2). We found addition of XL413 alone caused
noticeable accumulation of cells in late S phase (compare
Fig EV2A (i) with EV2B (i)). This effect of XL413 is as previously
described [40], and appears in the corresponding histogram as an
increased population of cells incorporating a low level of EdU
(Fig 3C, gray plot). The accumulation was partially rescued by
depletion of endogenous RIF1 (Fig EV2B (ii)), indicating that RIF1
and DDK act in opposition to control replication. In the presence
of XL413, ectopic expression of GFP-RIF1 however caused massive
accumulation of cells in S phase, along with the substantial reduc-
tion in the rate of DNA synthesis as measured by EdU incorpora-
tion (Fig EV2B (iii)). This aberrant profile suggests that ectopic
RIF1 expression combined with DDK inhibition impairs replication
rate to such an extent that the cells spend most of the cell divi-
sion cycle duplicating their DNA.
The replication rate was however not reduced by ectopic
expression of GFP-RIF1-pp1bs along with XL413 addition (Fig 3C,
green plot, and Fig EV1B (iv)), which produced profiles resembling
those caused by control GFP expression. RIF1 therefore requires
PP1 interaction to limit DNA synthesis rate and oppose DDK
activity.
We found moreover that an inhibitory effect of XL413 on cell
proliferation was enhanced in cells overexpressing GFP-RIF1, but
not GFP-RIF1-pp1bs (Appendix Fig S3). These results are consistent
with those described in yeast, where the effect of mutating DDK
components is relieved by loss of RIF1 [11–13,18].
To summarize, the removal of RIF1 can relieve inhibitory
effects of XL413 on DNA synthesis, showing that RIF1 and DDK
act in opposition to control replication. Conversely, ectopic
expression of GFP-RIF1 limits DNA synthesis rate in a way that
is strongly synergistic with DDK inhibition. This effect of RIF1
depends on its interaction with PP1, so that overall, the effects
of RIF1 on MCM phosphorylation, and the associated requirement
for DDK activity, are strikingly similar to those described in
yeast.
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Figure 3. RIF1 affects cellular DNA synthesis.
A Ectopic expression of GFP-RIF1 causes S-phase accumulation. Flp-In T-REx
293 cells with stable GFP, GFP-RIF1, or GFP-RIF1-pp1bs constructs were
grown with or without DOX for 2 days. Plot shows cell cycle distribution of
cells based on DNA content measured by flow cytometry.
B Effect of depletion and ectopic expression of RIF1 on DNA synthesis. Flp-In
T-REx 293 cells with stable GFP, GFP-RIF1, or GFP-RIF1-pp1bs constructs
were depleted for endogenous RIF1 by siRNA, and then after 1 day, GFP,
GFP-RIF1, or GFP-RIF1-pp1bs was induced by DOX addition. Two days later,
cells were pulse-labeled with 20 lM EdU for 15 min prior to flow
cytometry analysis of EdU incorporation. Overlaid histograms show EdU
incorporation in each condition. Note the x-axis scale is bi-exponential.
C Effect of depletion and ectopic expression of RIF1 on DNA synthesis in the
presence of 10 lM XL413. Cells were prepared and analyzed as in (B) but
with XL413 added at the same time as DOX.
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RIF1-PP1 is required for full origin licensing
Overexpression of GFP-RIF1 negatively impacted DNA synthesis
rate, especially in the context of DDK inhibition (Fig 3C), con-
firming that human RIF1-PP1 controls DNA replication by counter-
acting DDK-mediated MCM phosphorylation (Fig 2). If RIF1 acts
simply as a repressor of replication, RIF1 removal would be
expected to accelerate replication rate and potentially S-phase
progression. However, we noticed that depletion of RIF1 (in the
absence of XL413) in fact reduced the cellular DNA synthesis rate
(Fig 3B, compare black and blue profiles). This cannot be
explained by RIF1-PP1 acting only to limit MCM phosphorylation,
but rather suggests that RIF1 additionally has a novel, positive
function in stimulating DNA replication.
In our proteomic analysis, we noticed that the overall loading of
MCM2–7 proteins on chromatin was reduced in cells depleted for
RIF1 (Fig 4A). Importantly, all six MCM subunits were uniformly
reduced (by ~50% relative to control), indicating that chromatin
association of the entire MCM complex is compromised by RIF1
removal. This reduced overall MCM loading on chromatin stands in
contrast to the increased phosphorylation levels of certain sites on
the chromatin-associated MCM subunits (Fig 4B). To investigate
further, we analyzed chromatin-associated MCM3 protein in relation
to cell cycle stage, using a quantitative flow cytometry method [41].
This approach is suitable for analyzing unperturbed cell populations
to identify cell cycle-related changes that would be difficult to detect
by Western blotting. In brief, cells were treated with a low concen-
tration of non-ionic detergent to remove soluble proteins before fixa-
tion, and then, the detergent-resistant proteins were detected by
indirect immunofluorescence. This approach is analogous to extrac-
tion methods used in preparation of chromatin-enriched protein
fractions.
Following soluble protein extraction, cells were analyzed by flow
cytometry for abundance of MCM3 protein and simultaneously for
DNA content (Fig 4C). As described by Haland et al [41], the
observed pattern of detergent-resistant MCM3 in control cells is
consistent with the established behavior of MCM proteins during
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Figure 4. RIF1 is required for full replication licensing.
A Reduced chromatin association of ORC1 and MCM proteins in RIF1-
depleted cells. Amounts of chromatin-associated ORC and MCM proteins in
HEK293 cells treated with siCtrl or siRIF1 were analyzed by quantitative
proteomics as in Table 1. ORC6 was not detected perhaps due to its weak
association with other ORC subunits [75]. Histone H4 and CENP-B are
controls showing similar chromatin association in the presence or absence
of RIF1.
B Increased phosphorylation of ORC1 and MCM proteins in RIF1-depleted
cells. Relative changes in phosphorylation of chromatin-associated ORC
and MCM proteins were analyzed as in Table 1. Plot shows the log2
value for the residue most affected by depleting RIF1, for each protein.
Values are normalized by the change in chromatin association of each
protein.
C MCM loading onto chromatin is impaired in RIF1-depleted cells.
Abundance of chromatin-associated MCM3 in control and RIF1-depleted
HEK293 cells was analyzed by flow cytometry. Two-dimensional contour
plots are shown (x-axis: DNA content, y-axis: MCM3 protein abundance).
The y-axis is on a linear scale. Dashed and dotted boxes indicate G1 cells
with “high-MCM3” and “low-MCM3”, respectively.
D Reduced chromatin association of ORC1 in RIF1-depleted cells. Amounts of
chromatin-associated FLAG-ORC1 in control and RIF1-depleted FLAG-ORC1
HEK293 cells were analyzed by flow cytometry as in (C). Dashed and dotted
boxes indicate G1 cells with “high-FLAG-ORC1” and “low-FLAG-ORC1”,
respectively.
E ORC2 was similarly analyzed, in the same set of cells as in (D).
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the cell cycle: MCM3 is loaded onto the chromatin in G1 phase and
gradually dissociates during S phase concurrent with progress of
DNA replication, arriving at a minimum for cells in G2/M phase
(Fig 4C, left).
In the cells depleted for RIF1, MCM3 association with chromatin
during G1 phase was reduced (Fig 4C, right), with the maximum
MCM3 level in RIF1-depleted cells (“top end” of the G1 population)
much lower than for control cells. In siCtrl cells, the ratio of
“high-MCM3” to “low-MCM3” cells (dashed and dotted boxes,
respectively) was almost 1:1 with 47% of cells in the “high-MCM3”
category. In contrast, only 13% of RIF1-depleted cells displayed a
“high-MCM3” load on chromatin (Fig 4C). RIF1 depletion itself does
not significantly affect cell cycle distribution (data not shown), and
so, this reduced MCM loading is not due to premature initiation of S
phase. Together with the mass spectrometry data, these data
demonstrate that MCM loading on chromatin is significantly
impaired in RIF1-depleted cells, indicating a positive role of RIF1 in
origin licensing during G1 phase. The reduction of chromatin-
associated MCM4 protein caused by RIF1 depletion was confirmed
to be reproducible in Western blotting experiments (Fig EV3A).
Moreover, ectopic expression of GFP-RIF1, but not GFP-RIF1-pp1bs,
rescued this reduced MCM4 chromatin association, implying that
interaction of RIF1 with PP1 is important to ensure full licensing
(Fig EV3A).
RIF1-PP1 protects ORC1 protein from proteasome-dependent
destruction in G1 phase
Seeking the mechanism through which RIF1-PP1 might regulate
origin licensing, we noticed a modest reduction of ORC1 protein
in the chromatin-enriched fraction of RIF1-depleted cells (Fig 4A).
Other ORC subunits are in contrast either unchanged, or slightly
increased (Fig 4A). Human ORC1 protein is known to behave dif-
ferently from other ORC proteins: while other ORC subunits
remain associated with chromatin throughout the cell cycle,
ORC1 is stable and chromatin-associated only during G1 phase
[5,6,42]. Outside of G1 phase, cyclin A–CDK2 phosphory-
lates ORC1, and this phosphorylation triggers ORC1 degradation
by the proteasome [5,6,42], though the precise phosphorylation
sites responsible are not yet determined. Importantly, ORC1
protein is therefore proposed to be a limiting factor for origin
licensing [5].
Based on our observation of reduced ORC1 chromatin associa-
tion upon RIF1 depletion, we hypothesized that RIF1-PP1 protects
ORC1 from destruction in G1 phase by ensuring that it is kept
unphosphorylated. In this model, loss of RIF1 would result in unti-
mely phosphorylation and degradation of ORC1, and a consequent
defect in MCM loading, as observed (Fig 4C). To test this hypothe-
sis, we assessed the effect of depleting RIF1 on the abundance of
chromatin-associated ORC1 (Fig 4D) using a HEK293-derived cell
line that ectopically expresses FLAG-tagged ORC1 [6]. Importantly,
this FLAG-ORC1 protein is subject to cell cycle-controlled degrada-
tion and shows abundance and chromatin association fluctuation
during the cell cycle like endogenous ORC1 [6,42]. Both endogenous
ORC1 and FLAG-ORC1 proteins are almost exclusively associated
with chromatin in G1 phase [5,6,42], so that the abundance of chro-
matin-associated FLAG-ORC1 mirrors cellular abundance of ORC1
protein.
Using a “protein extraction-flow cytometry” approach similar to
that described for MCM3, we found that FLAG-ORC1 protein is
hardly present in G2 cells and becomes chromatin-associated only
in G1 phase (Fig 4D, left), with 32% of Control G1 phase cells
showing high levels of ORC1 chromatin association. The amount
of FLAG-ORC1 that becomes chromatin-associated was reduced in
RIF1-depleted cells, with only 23% of G1 phase cells showing
high-level association (Fig 4D, right), consistent with the sugges-
tion that RIF1 is needed to stabilize ORC1. The reduction was even
greater upon depletion of RIF1 from HeLa cells expressing GFP-
fused ORC1 and mCherry-PCNA (Fig EV3B–D), with the proportion
of G1 phase cells showing highest ORC1 chromatin association
dropping from 27 to 13% (differing transfection efficiency may
account for the higher impact of siRIF1 in this cell line compared
to that in Fig 4D). We confirmed moreover that MCM3 chromatin
association is also reduced when RIF1 is depleted in the FLAG-
ORC1 cells (Fig EV3E). In contrast to ORC1, we found that ORC2
protein remains chromatin-associated stably throughout the cell
cycle (Fig 4E, left panel), consistent with previous studies [5,42].
ORC2 chromatin association was unaffected by RIF1 depletion
(Fig 4E, right panel), in agreement with our proteomics data
(Fig 4A). Overall, these results demonstrate that RIF1 is required
for efficient stabilization of the ORC1 protein and its chromatin
association during G1 phase.
If RIF1 acts with PP1 to protect ORC1 from degradation, then PP1
inhibition should increase ORC1 phosphorylation leading to its
degradation. To test this prediction, we analyzed ORC1 abundance
when PP1 activity is inhibited. Cells expressing FLAG-ORC1 were
treated with the PP1 inhibitor tautomycetin [43] for 4 h and the
ORC1 protein abundance was analyzed (Fig 5A). FLAG-ORC1 abun-
dance and chromatin association were substantially reduced in cells
treated with tautomycetin (Fig 5A, right), and chromatin association
of MCM3 was also reduced in the same cells (Fig 5B, right). Note
that 4-hr treatment with 5 lM tautomycetin did not noticeably
change cell cycle distribution (Fig EV3F); therefore, the changes in
ORC1 and MCM3 levels are not due either to impaired exit from
mitosis, or to other cell cycle defects. The effects of tautomycetin
indicate that, along with RIF1, PP1 activity is important to protect
ORC1 protein from degradation, and is essential for full replication
licensing in human cells.
To confirm that RIF1 protects ORC1 from degradation by the
proteasome, we analyzed the abundance of FLAG-ORC1 when
proteasomal degradation is inhibited. If the reduced ORC1 in RIF1-
depleted cells is due to accelerated proteasome-mediated degrada-
tion, proteasome inhibition should rescue the reduction in ORC1
protein level. To test this, we treated control and RIF1-depleted cells
with proteasome inhibitor MG-132 for 4 h prior to analysis by flow
cytometry. Incubation of control cells with MG-132 slightly
increased FLAG-ORC1 abundance in G1 cells, as well as at other cell
cycle stages (Fig 5C), indicating that some ORC1 protein is proteaso-
mally degraded even in the presence of RIF1. In RIF1-depleted cells,
proteasome inhibition partly stabilized FLAG-ORC1 protein in G1 as
well as other cell cycle phases (Fig 5C), such that the maximum
FLAG-ORC1 level in siRIF1 cells treated with MG-132 is comparable
to that in control cells. In the GFP-ORC1-expressing HeLa cell line,
G1 phase destabilization of GFP-ORC1 due to RIF1 depletion was
fully rescued by MG-132 treatment (Fig EV3G). Also with this cell
line, proteasome inhibition led to increased ORC1 at other cell cycle
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phases as expected. Chromatin association of MCM3 protein was
assessed in the FLAG-ORC1 cell line in the same experiment
(Fig 5D). Incubation of cells with MG-132 led to a clear rescue of
the reduced MCM3 chromatin association caused by siRIF1, to a
level comparable to control cells (Fig 5D). Overall, these results are
consistent with our proposal that RIF1-PP1 acts to stabilize ORC1
protein and protect it from proteasomal degradation, hence promot-
ing MCM loading during G1 phase.
Reduced origin licensing due to Rif1 depletion leads to increased
origin spacing
As described above, we found a modest but reproducible reduc-
tion of origin licensing in RIF1-depleted and in PP1-inhibited
cells (Figs 4 and 5). In normal cells, considerably more sites are
loaded with MCM proteins than are required to complete chro-
mosomal DNA replication, so that a substantial number of
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Figure 5. RIF1 and PP1 protect ORC1 from cell cycle-specific degradation during G1 phase.
A Inhibition of PP1 destabilizes ORC1. FLAG-ORC1 HEK293 cells were treated for 4 h with 5 lM tautomycetin prior to flow cytometry, and chromatin-associated FLAG-
ORC1 analyzed as in Fig 4D.
B Inhibition of PP1 causes reduced MCM loading. Chromatin-associated MCM3 protein was analyzed in the same set of the cells as in (A).
C Reduced ORC1 chromatin association in RIF1-depleted cells is partly rescued by inhibiting the proteasome. Control and ORC1-depleted FLAG-ORC1 HEK293 cells were
treated for 4 h with 20 lM MG-132 (or DMSO) prior to flow cytometry analysis.
D Proteasome inhibition rescues MCM3 chromatin loading. Chromatin-associated MCM3 was analyzed in the same set of cells as in (C).
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licensed origins remain “dormant” in an unchallenged S phase
[44,45]. We investigated the effect of Rif1 on frequency of origin
initiation in unperturbed S phase, and also in cells treated with
hydroxyurea (HU) which interrupts replication fork progression
and stimulates dormant origin activation [45]. Interorigin distance
(IOD) was analyzed using the DNA fiber technique (Fig 6A) in
control and RIF1-depleted cells. Without HU (Fig 6B), the IOD in
siCtrl cells ranges from around 30 to 130 kb, with a median of
63.0 kb (Fig 6B, open bars). RIF1-depleted cells show a broader
range of IOD values with a statistically significant increase in
the median value to 77.0 kb (P = 0.001), and an increased inci-
dence of origin spacings above 120 kb (Fig 6B, black bars). The
spacing of active origins is therefore increased by Rif1 depletion,
consistent with a reduction in licensing. Upon treating siCtrl cells
with 200 lM HU, activation of dormant origins occurs, as
evidenced by a noticeably increased proportion of IOD values
shorter than 40 kb (Fig 6C, compare open bars in pink shaded
region with open bars in Fig 6B), and a reduction in the median
IOD to 45.9 kb. RIF1-depleted cells treated with HU showed
noticeably fewer IOD values < 40 kb (Fig 6C, black bars within
pink shaded region), and a longer IOD median (55.2 kb).
Removal of RIF1 therefore also compromises the availability of
dormant origins for activation upon HU treatment. The increase
in median IOD caused by RIF1 depletion both in the presence
and absence of HU confirms that RIF1 removal causes an overall
decrease in the total number of origins that initiate replication.
In agreement, RIF1 depletion also led to a decrease in the over-
all DNA synthesis rate in the presence and absence of HU
(Figs 3B and EV4A). The speed of progress of replication forks
was however not significantly changed by RIF1 depletion
(Fig EV4B). These observations are generally consistent with a
requirement for human RIF1 to mediate full origin licensing
(Figs 4–6), in addition to its role in limiting MCM phosphoryla-
tion levels (Fig 2 and Table 1).
Discussion
While RIF1 was known to affect DNA replication throughout
eukaryotes, it has been unclear whether its molecular mechanism of
action is conserved, partly because of the complex replication
phenotypes associated with loss of mammalian RIF1. Our studies
demonstrate that human RIF1 can interact with all three PP1
isoforms and is important to prevent excessive phosphorylation of
MCM proteins (Figs 1 and 2, and Table 1). This function parallels
the molecular action of yeast RIF1 in limiting origin initiation, and
demonstrates that PP1 targeting is a central molecular function of
RIF1 conserved throughout evolution. We identified phosphoryla-
tion sites on human MCM proteins affected by RIF1, and quantita-
tively assessed the impact of depleting RIF1 (Table 1). Although
PP1 itself has poor substrate specificity, phosphorylated residues
affected by RIF1 appear confined to particular regions, notably the
regulatory N-terminal domains of MCM2 and MCM4. This suggests
that RIF1 may direct PP1 to dephosphorylate specific regions of the
MCM complex. Interestingly, although MCM2 and MCM4 are
located on the opposite sides of a single MCM hexamer, their N-
termini are juxtaposed in the MCM double hexamer formed during
origin licensing [46]. Further structural studies will be needed to
understand how particular domains of the MCM complex are specif-
ically affected by RIF1-PP1.
Analysis of EdU incorporation (Fig 3) suggested that RIF1 might
have other effects on DNA replication control beyond simply acting
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Figure 6. Effect of RIF1 on origin activation in unperturbed S phase.
A Specimen images of DNA fibers sequentially labeled with CldU and IdU.
siControl- and siRIF1-treated Flp-In T-REx 293 cells (with integrated GFP)
were incubated for 4 h in the presence of 200 lM HU, with pulse-labeling
using CldU (visualized red) then IdU (visualized green) in the final 40 min.
B Distribution of origin distance in siCtrl (open bars) and siRIF1 (black bars)
cell lines, treated as described in (A) but with no HU treatment. For
statistical analysis of IOD data, Mann–Whitney–Wilcoxon test was
performed using R (version 3).
C Distribution of origin distance in siCtrl (open bars) and siRIF1 (black bars)
cell lines, treated as described in (A) including HU treatment. The area
corresponding to IOD values shorter than 40 kb is marked by pink
background.
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as a suppressor of initiation. In particular, depletion of endogenous
RIF1 leads to reduced DNA synthesis, suggesting that RIF1 might
positively regulate replication. Further investigation revealed a
previously unappreciated role for RIF1 in ensuring optimal replica-
tion licensing. Along with PP1, RIF1 contributes to the G1-specific
stabilization of ORC1, ensuring that cells are fully competent for
MCM loading and pre-RC assembly at the correct cell cycle phase.
The fact that RIF1 depletion causes only a mild defect in ORC1
loading but has a somewhat larger impact on MCM loading
(Fig 4A, C and D) is as expected, since under normal circum-
stances, multiple MCM complexes are believed to be loaded at
each single ORC site. Overall, effects of RIF1 that previously
seemed paradoxical can be explained by the discovery that RIF1-
PP1 has two functions in replication control as illustrated in Fig 7:
first, the promotion of origin licensing by protecting ORC1 from
degradation, and second, suppression of origin firing by counter-
acting DDK.
We found that either loss of RIF1, or inhibition of PP1, leads to
an almost twofold reduction in replication licensing levels as
measured by MCM association with chromatin in proteomic and
flow cytometry experiments (Figs 4 and 5). The magnitude of this
reduction is comparable to the drop in DNA synthesis rate in RIF1-
depleted S-phase cells, which incorporate EdU at only about 58% of
the normal rate (Figs 3B and EV4A). RIF1 depletion does also cause
a fairly mild increase in interorigin distance, our fiber analyses
showing an increase of 10–20 kb in typical origin spacing. While
consistent with the reduced replication licensing, this decrease in
the density of initiating origins is not sufficient to fully account for
the drop in DNA synthesis rate caused by RIF1 depletion.
How can loss of RIF1 substantially compromise replication
licensing and DNA synthesis rate, while only mildly increasing
IOD? One potential explanation may be that some of the effects of
RIF1 on replication licensing operate at a broader level than is
detectable by fiber analysis [17,19,22]. Fiber analysis measurements
of IOD are effective for identifying changes occurring at a local
level, but changes in replication dynamics that involve entire
chromosome domains cannot be visualized through fiber measure-
ments. For example, if RIF1 depletion only mildly affects licensing
of most regions, but in some areas causes failure to license entire
clusters of replication origins, then the effect will be to compromise
the overall replication rate more than is reflected by local IOD
measurements (as group of origins that failed to license are
invisible in fiber analysis). RIF1 loss is known in some contexts to
cause large-scale effects on groups of origins: for example, RIF1
removal affects the replication timing program of human and
mouse cells such that entire domains—encompassing hundreds of
kilobases and containing multiple replication origins—show
substantially altered replication timing [17,19].
The exact molecular mechanism through which RIF1 stabilizes
ORC1 will require further investigation, especially since the phos-
phorylation site(s) directing degradation of ORC1 is yet to be identi-
fied. While we cannot completely rule out the possibility of an
indirect effect, it is interesting to note that the ORC1 Ser273 residue,
which showed significantly increased phosphorylation on RIF1
depletion in our proteomic analysis, lies close to a potential destruc-
tion box at residues 236–244, and to a PP1 interaction motif at resi-
dues 264–268. PP1 interaction motifs are characteristic of PP1
substrates as well as PP1-targeting subunits, so this motif could
potentially mediate PP1 docking to dephosphorylate Ser273 and
stabilize the ORC1 protein.
Two other proteins required for origin licensing in human cells,
Cdc6 and Cdt1, are also regulated through phosphorylation by
CDK2. Phosphorylated Cdc6 is exported from the nucleus, while
phosphorylation of Cdt1 targets it for degradation [47,48]. We tested
whether these proteins might also be regulated by RIF1. Cdc6 local-
ization was however not altered by RIF1 depletion (Fig EV5A),
while any effect of RIF1 on Cdt1 stability appears very slight
(Fig EV5B).
Replication timing
Removal of either human or mouse RIF1 causes large-scale switches
in the replication time of extended chromosome domains [17,19]. A
recent paper used chromatin immunoprecipitation (ChIP) to demon-
strate that in mouse embryonic stem (ES) cells, RIF1 is bound
mainly to a subset of late-replicating regions, and that the same
regions tend to display earlier replication timing in cells deleted for
RIF1. How can this apparently domain-specific role for RIF1 in repli-
cation timing be reconciled with the effects on licensing and origin
activation described here? Resolving this issue clearly requires
further investigation, but one possibility is that RIF1 interacts with
different classes of chromosomal domains at various cell cycle
stages to mediate its distinct functions. During mitosis, RIF1 is disso-
ciated from chromatin but re-associates as cells re-enter G1 phase.
The early G1 phase chromatin association has been investigated
only microscopically but appears to be general [17,19,25], consis-
tent with the possibility that RIF1 may associate genomewide at the
right time to support the establishment of licensed origins. Once
cells enter S phase, however, RIF1 has been microscopically
Figure 7. Model of DNA replication control by RIF1-PP1.
In normal cells (left panel), RIF1 acts with PP1 to stabilize ORC1, promoting its
loading at potential DNA replication origin sites at M/G1 phase (top). ORC1 then
stimulates MCM loading, to license origins in G1 phase (middle). When cells enter
S phase, RIF1 counteracts DDK-mediated phosphorylation of the MCM complex
to limit the number of origins activated (bottom). In the absence of RIF1 (right
panel), ORC1 is short-lived and its chromatin association reduced (top), so that
fewer origins are licensed in G1 (middle). During S phase, however, increased
MCM phosphorylation means that a larger fraction of licensed origins are
activated (bottom). For simplicity, the ORC2–5 subunits (which are chromatin-
associated throughout the cell cycle) are omitted.
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described as showing a more limited binding pattern, associating
mainly with unreplicated DNA in heterochromatic, late-replicating
regions [17,19,25], consistent with the pattern identified by ChIP
in ES cells [22]. In this configuration, RIF1 would be positioned
such that it could delay replication by preventing MCM helicase
activation until the right time in S phase. If RIF1 does change its
chromatin association as the cell cycle progresses, then it is
possible that the ChIP localization of RIF1 reported by Foti et al
[22] in ES cells mainly represents the S-phase pattern, since ES
cells appear to spend most of interphase replicating their DNA
[49,50].
The model outlined above proposes that in early G1 Rif1 associ-
ates genomewide and supports replication licensing, and then later
once cells enter S phase, it dissociates specifically from early
domains and is left only at some late domains where it delays repli-
cation. While this suggestion appears to fit with most previous
observations, other models are of course possible. In particular,
there is compelling evidence that mouse RIF1 mediates interdomain
organization during G1 phase, potentially impacting on the replica-
tion timing program [22].
A further possibility is that RIF1 affects the replication timing
program by ensuring “effectiveness of licensing” of replication
origins. Multiple MCM complexes can be loaded per ORC complex
[51], and it is suggested that the number of MCM complexes at an
origin determines the timing and the efficiency of its activation
[52,53]. Reduced ORC1 half-life in the absence of RIF1 may shorten
the window of opportunity for MCM loading at each origin, poten-
tially resulting in a smaller number of MCM complexes loaded,
which would lead to an apparent reduction in licensing as observed
in our results. This would in turn disturb the replication program, if
MCM complex number at each origin is indeed the major determi-
nant of replication timing.
It should be noted that the possibilities outlined above are not
incompatible with each other, and that these mechanisms may func-
tion either independently, or in concordance so that RIF1 acts
through several mechanisms each contributing to sharpen the repli-
cation timing program.
Dormant origins and damage sensitivity
The local activation of dormant origins upon replication stress—for
example, due to inhibition of replication fork progression—is
thought to protect cells from replication inhibitors, presumably by
providing a “backup” mechanism to replicate the DNA when repli-
cation forks irreparably stall or collapse [54–56]. We found that Rif1
depletion leads not only to an increase in origin spacing in normal S
phase, but also to a reduction in the availability of dormant origins
following replication stress. One consequence of limiting the
number of available dormant origins is increased sensitivity to repli-
cation-inhibiting drugs, such as hydroxyurea or aphidicolin. Inter-
estingly, cells lacking RIF1 are very sensitive to both hydroxyurea
and aphidicolin [25]. We suspect that the hypersensitivity of cells
lacking RIF1 to replication inhibitors may reflect the fact they have
fewer dormant origins available to respond effectively. Overall, the
dual function we have identified for RIF1 in replication control—
stimulating replication licensing but repressing origin activation—
may explain why simple removal of RIF1 allows unimpeded
replication to progress without obvious problems, but leaves the cells
more sensitive to disruption of affected pathways. Thus, the vulnera-
bility and fragility of replication control caused by deregulation of
RIF1 are exposed either by interrogating dormant origin availability
(using aphidicolin or hydroxyurea), or by compromising MCM phos-
phorylation (by DDK inhibition with XL413).
Is RIF1 function in origin licensing conserved?
It is unclear whether the function of RIF1 in origin licensing is
conserved. Chromatin association of hamster ORC1 is controlled at least
in part through regulated cell cycle localization [57], and it remains to
be investigated whether either the localization or stability of rodent
licensing components is regulated by RIF1. In yeast, ORC1 is associated
with DNA replication origins throughout the cell cycle, and there is no
clear evidence of a role for yeast Rif1 in supporting licensing.
Other functions of RIF1 and ORC1
ORC1 has been implicated in a number of cellular functions in addi-
tion to replication licensing, most notably centrosome replication
and as a consequence cilia formation [58–60]. Further investigation
will be needed to ascertain whether reduced ORC1 protein in RIF1-
deficient cells causes defects in centrosome control and cilia forma-
tion. Origin licensing proteins, including ORC1, are linked to Meier-
Gorlin syndrome [59,61]. Our discovery that RIF1 supports licensing
through ORC1 therefore raises the intriguing possibility that RIF1
mutations could potentially also contribute to Meier-Gorlin
syndrome.
Mammalian RIF1 affects various pathways of DNA damage
recognition and repair [13]. RIF1 is recruited to DSB sites through
interaction with 53BP1, where it directs cell cycle-dependent DSB
repair pathway choice [34,62–64]. RIF1 also acts in resolution of
ultrafine DNA bridges that may result from replication fork failure
[65]. Our demonstration here that human RIF1 is a PP1-targeting
subunit raises the possibility that other functions of RIF1—in
particular repair pathway choice—are mediated by controlling
phosphorylation of components of the network that directs DNA
repair.
Materials and Methods
PCR primers
The following PCR primers were used to mutagenize the PP1 inter-
action motifs of human RIF1 (mutated nucleotides in lower-case
letters):
SH568: 50-GCTTTCAAAATTGAATGATACCATTAAGAATTCAG-30
SH569: 50-GCAATggcAGCggcCTTTTTAATCATGGGTGCTCCAC-30
SH570: 50-GgccGCTgccATTGCTTGGAAGAGTTTAATAGATAATTTT
GC-30
SH571: 50-CAGGTTCATTCGGGGAGTTCCC-30
SH572: 50-CTATGGAATTGAATGTAGGAAATGAAGCTAGC-30
SH573: 50-CAGGTGATGAGATTTCATCTTCTTGGGATCTTTTTAGTC
CTCTCTTggcggcGCTCGTAGACGGAGAAGCCAAA-30
SH574: 50-GAAGATGAAATCTCATCACCTGTTAATAAGGTTCGCCG
TGcCTCCgccGCAGATCCAATATACCAAGCAGGA-30
SH575: 50-CGAGTCTTCACCTGCTGCTCATGATATATTCTG-30
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Plasmids
The GFP-RIF1 constructs used in this study are based on
pcDNA5/FRT/TO-GFP-RIF1 [34], which carries human RIF1 cDNA
fused to GFP at its N-terminus. The cDNA corresponds to the
shorter of two reported splicing variants [66], and encodes a
2,446-amino acid protein (corresponds to Q5UIP0-2 in the Uniprot
protein database). To mutagenize the N-terminal PP1 interaction
motif of RIF1, the EcoRI-XmaI fragment of plasmid pcDNA5/FRT/
TO-GFP-RIF1 was replaced using the In-Fusion HD cloning
system (Clontech) by two PCR fragments amplified with primers
SH568 & SH569, and SH570 & SH571, respectively. To muta-
genize the C-terminal PP1 interaction motifs of RIF1, the NheI-AarI
fragment of the plasmid was similarly replaced by two PCR frag-
ments amplified with primers SH572 & SH573, and SH574 &
SH575, respectively. Introduction of the designed mutations and
the absence of unexpected mutations was confirmed by DNA
sequencing.
Cell lines and culture conditions
Cells were cultivated in Dulbecco’s modified Eagle’s minimal
medium supplemented with 10% fetal calf serum at 5% CO2 and
ambient O2 at 37°C. Tetracycline-free fetal calf serum (Labtech,
FB-1001T/500) was used for cultivation of cell lines with tetracy-
cline-inducible constructs. Appropriate antibiotics were added for
selection of the constructs.
The Flp-In T-REx 293 cell line (Invitrogen) was used to create
stable cell lines for the ectopic expression of GFP, GFP-RIF1, and
GFP-RIF1-pp1bs. To construct cell lines, pOG44 [67] and the
pcDNA5/FRT/TO-based plasmids carrying GFP, GFP-RIF1, or
GFP-RIF1-pp1bs genes were mixed in 9:1 molar ratio and used for
transfection of Flp-In T-REx 293 cells with Lipofectamine 3000
(Invitrogen). Transfections and hygromycin B selection of stably
transfected cells were performed as described by the manufacturer.
Clones were tested for doxycycline-dependent induction of GFP
fusion proteins by Western blots and microscopy.
To assess the effect of depleting and ectopically expressing RIF1,
cells were transfected with either control siRNA or siRNA against
human RIF1. The following day, cells were split and cultivated for a
further 2 days with 1 lM DOX to induce GFP, GFP-RIF1, and GFP-
RIF1-pp1bs proteins. Where noted, XL413 was added at 10 lM
together with DOX.
The stable HEK293-derived cell line expressing FLAG-ORC1 was
previously described [6]. The stable HeLa-derived cell line express-
ing FLAG-GFP-ORC1 mCherry-PCNA will be described elsewhere
more in detail.
U2OS and HEK293 cell lines were previously described [68,69]
and were obtained from Public Health England.
List of siRNA used in this study
1 Human RIF1 siRNA (Dharmacon, D-027983-02).
2 Human PP1a siRNA (Santa Cruz Biotechnology, sc-36299).
3 Human PP1b siRNA (Santa Cruz Biotechnology, sc-36295).
4 Human PP1c siRNA (Santa Cruz Biotechnology, sc-36297).
5 Control siRNA against luciferase (Dharmacon,
D-001100-01).
Chromatin fractionation and immunoprecipitation
Chromatin-enriched protein fractions were prepared essentially as
described [70]. Protein concentrations in chromatin-enriched frac-
tions were determined using the Bio-Rad RC DC Protein assay kit.
For Western blots, equal amount of total proteins were loaded on
each lane, and for quantification, the results were generally further
normalized by total protein using Bio-Rad stain-free gels. When
stain-free normalization was unavailable, equal loading on the blot
was confirmed by Ponceau S staining.
Immunoprecipitation of GFP, GFP-RIF1, and GFP-RIF1-pp1bs
proteins was carried out using GFP-Trap beads (ChromoTek)
essentially as described by the manufacturer. Benzonase (Millipore)
treatment was performed before the preparation of soluble cell
lysates to release chromatin-associated proteins.
Phosphoproteomic analysis of chromatin-associated proteins
Chromatin-enriched protein fractions were prepared from HEK293
cells transfected either with control siRNA (“RIF1+” cells) or RIF1
siRNA (“RIF1” cells) as described above. The chromatin pellet
was resuspended in 1% SDS/100 mM tetraethylammonium
bromide (TEAB). Proteins were reduced by 10 mM tris(2-carboxy-
ethyl)phosphine for 1 h at 55°C, followed by alkylation for
30 min at room temperature in the presence of 17 mM iodoac-
etamide. Proteins were then precipitated by addition of six
volumes of cold acetone. Protein pellets were separated by
centrifugation and resuspended in 100 mM TEAB buffer. Proteins
were digested by either (i) trypsin (Pierce) alone or (ii) trypsin
followed by Asp-N endopeptidase (Thermo Scientific). After
removing insoluble materials by centrifugation, the supernatants
were used for TMTduplex isobaric mass tag (Thermo Scientific)
labeling reactions as described by the manufacturer. Roughly
equal masses of TMT-labeled peptides from RIF1+ and RIF1 cells
were mixed, and fractionated by a high pH reverse-phase HPLC
[71] into 24 concatenated fractions per digestion. For each frac-
tion, phosphopeptides were enriched by MagResyn Ti-IMAC beads
(Resyn Bioscience) using KingFisher Flex Magnetic Particle
Processor (Thermo) as described [72]. The peptide samples were
analyzed using an Orbitrap Fusion mass spectrometer (Thermo
Scientific). Identification and relative quantification of phospho-
peptides were carried out using MaxQuant software (ver. 1.5.3.8).
Relative enrichment of phosphorylation at each identified residue
was calculated by dividing the reporter signal intensity obtained
from RIF1- cells by that from RIF1+ cells. Peptides that did not
associate with the Ti-IMAC resin were analyzed in parallel, and
were used for normalization of the phospho-enriched datasets.
For example, in the phosphorylated peptide sample, MCM4-phos-
phoS23 from RIF1 cells was measured as 2.92 times that from
RIF1+ cells. In RIF1 cells, however, total MCM4 on chromatin is
0.52 times that in the RIF1+ cells (based on measurements of 64
peptides). So within the population of MCM4 molecules that are
chromatin-associated, MCM4-phosphoS23 must be 5.63-fold
increased by RIF1 depletion. Protein sequence database used was
Uniprot human reference proteome (release 2015_08). The protein
sequences and amino acid numbering of MCM proteins presented
in Table 1 are based on the canonical sequences of Uniprot
entries, P49736 (MCM2_HUMAN), P25205 (MCM3_HUMAN),
ª 2017 The Authors EMBO reports
Shin-ichiro Hiraga et al Dual control of DNA replication by RIF1 EMBO reports
13
P33991 (MCM4_HUMAN), P33992 (MCM5_HUMAN), Q14566
(MCM6_HUMAN), and P33993 (MCM7_HUMAN).
Flow cytometry
For DNA content analysis by flow cytometry, cells were recovered
by trypsinization, and fixed in 70% ethanol. Cells were spun down,
resuspended in PBS containing 50 lg/ml propidium iodide,
50 lg/ml RNase A, and 0.1% Triton X-100, and incubated at room
temperature for 1 h (protected from light). DNA content per cell
was analyzed on a Becton Dickinson FACSCalibur using FL2-A. Cell
cycle distribution was measured using FlowJo software. Doublet
discrimination was performed by setting a gate on a 2-D plot of
FSC-A and FCS-H values.
For EdU pulse-label experiments, cells were labeled for 15 min
with 20 lM 5-ethynyl-20-deoxyuridine (EdU). Cells were collected,
fixed, permeabilized, and stained essentially as described [73] using
Click-iT Plus EdU Alexa Fluor 647 Flow Cytometry Assay Kit
(Molecular Probes). DNA was stained with 0.5 lg/ml DAPI instead
of propidium iodide. Cells were analyzed using a Becton Dickinson
LSRFortessa flow cytometer. Data were analyzed by FlowJo soft-
ware. Doublet discrimination was performed by setting a gate on a
2-D plot of FSC-A and FCS-H values.
Chromatin-associated proteins were analyzed by flow cytometry
essentially as described [41] with modifications. After extraction,
cells were stored in 70% ethanol at 20°C. We included a blocking
step with 4% non-fat dried milk before the immunostaining. For
antibody staining, cells were suspended in PBS with 0.1% Igepal
CA-630 to a density of 107 cells/ml, and 0.1 ml of cell suspension
(=106 cells) were used. Antibodies were diluted in PBS containing
3% BSA. All the washing steps were performed using PBS with
0.1% Igepal CA-630. After immunostaining, cells were resuspended
in PBS containing 0.1% Igepal CA-630 and 0.5 lg/ml DAPI and were
kept in the dark prior to analysis by Beckon Dickinson LSRFortessa.
Data were analyzed by FlowJo software. Doublet discrimination was
performed by setting a gate on a 2-D plot of FSC-A and FCS-H
values. To assess the effect of MG-132 and tautomycetin, culture
medium was replaced with fresh culture medium containing either
DMSO, 20 lM MG-132 (Invivogen), or 5 lM tautomycetin (Tocris),
and cultivation was continued for 4 h prior to collecting cells.
For analysis of GFP-ORC1 mCherry-PCNA HeLa cells, cells were
extracted and fixed essentially as above, except that the fixation was
only 10 min. After washing in PBS containing 0.1% Igepal CA-630,
cells were immediately stained with DAPI and fluorescence from
GFP and mCherry analyzed by Becton Dickinson LSRFortessa.
List of antibodies used in this study
The following antibodies were used for Western blotting:
1 RIF1; Bethyl Laboratories; A300-568A; rabbit polyclonal
2 GFP; Abcam; ab290; rabbit polyclonal
3 GFP; ChromoTek; rat monoclonal [3H9]
4 MCM4; Abcam, ab4459; rabbit polyclonal
5 p-S40-MCM2; Abcam; ab133243; rabbit monoclonal [EPR4170
(2)]
6 p-S53-MCM2; Bethyl Laboratories; A300-756A; rabbit polyclonal
7 PP1a; Santa Cruz Biotechnology; sc-271762; mouse monoclonal
[G-4]
8 PP1b; Santa Cruz Biotechnology; sc-373782; mouse monoclonal
[C-5]
9 PP1c; Santa Cruz Biotechnology; sc-6108; goat polyclonal
10 Tubulin; Santa Cruz Biotechnology; sc-53030; rat monoclonal
[YOL1/34]
Following antibodies were used for flow cytometric analysis of
chromatin-associated proteins at indicated dilutions:
1 Cdt1 antibody; Abcam ab202067, at 1/100 dilution
2 FLAG tag antibody [M2]; Sigma F-1804, at 1/300 dilution
3 MCM3 antibody; Santa Cruz sc-9850, at 1/300 dilution
4 ORC2 antibody; Abcam ab31930, at 1/200 dilution
5 Alexa Fluor 488-conjugated anti-mouse IgG (ab150109), at 1/
2,000 dilution
6 Alexa Fluor 568-conjugated anti-mouse IgG (ab175700), at 1/
2,000 dilution
7 Alexa Fluor 647-conjugated anti-goat IgG (ab150135), at 1/2,000
dilution
8 Alexa Fluor 647-conjugated anti-rabbit IgG (ab150063), at 1/
2,000 dilution
For immunoprecipitation of endogenous RIF1 protein, Abcam
ab70254 was used. For microscopic observation of Cdc6 protein,
Abcam ab188423 was used.
Cell viability assay using CellTiter-Glo
A total of 1,000–5,000 cells in 100 ll of medium were transferred to
wells of white 96-well plates (Greiner) with the indicated concentra-
tion of XL413. After 3 days of incubation, 100 ll of CellTiter-Glo
assay reagent (Promega) was added to each well. Luminosity of
each well, which represents total ATP level derived from viable
cells, was measured using GloMAX luminometer (Promega). Values
were normalized to the values without XL413 addition.
DNA fiber analysis
Exponentially growing cells were pulse-labeled with 50 lM CldU
(Sigma C6891) for 20 min followed by 250 lM IdU (I7125) for
20 min. Labeled cells were trypsinized and resuspended in cold PBS
at an approximate density of 2.5 × 105 cells/ml; 2 ll of the cell
suspension was placed toward the end of a regular microscope slide,
pre-cleaned with EtOH 70%. Cells were lysed on the slide by adding
10 ll of fresh pre-warmed (30°C) spreading buffer (200 mM Tris–
HCl pH 7.4, 50 mM EDTA, 0.5% SDS). After 6 min of incubation,
the slides were tilted at a 10–15° angle to allow the DNA suspension
to run slowly and spread down the slide. Slides were air-dried for at
least 20 min and fixed in cold (20°C) methanol–acetic acid (3:1).
Slides were stored at 4°C before the following steps. DNA was dena-
tured by incubation of the slides in 2.5 M HCl at RT in a Coplin
staining jar for 30 min. Slides were rinsed 3× to completely remove
HCl and blocked by incubation for 1 h in 1% BSA, 0.1% Triton
X-100, PBS. Blocking was followed by incubation with primary
antibodies diluted in blocking solution for 1 h at RT in humidity
chamber (anti-CldU, Abcam ab6326, 1:100; anti-IdU, BD 347580,
1:100; anti-ssDNA, Millipore MAB3034, 1:100). Slides were washed
three times in PBS and incubated with the following secondary anti-
bodies diluted 1:300 in blocking solution (anti-rat IgG Alexa Fluor
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594, Molecular Probes A-11007; anti-mouse IgG1 Alexa Fluor 488,
Molecular Probes A-21121; anti-mouse IgG2a Alexa Fluor 350,
Molecular Probes A-21130). Slides were air-dried and mounted with
Prolong (Invitrogen). DNA fibers were imaged under a Zeiss Axio
Imager.M2 microscope equipped with Zeiss MRm digital camera,
with a Zeiss Plan-Apochromat 63×/1.40 Oil objective lens. Images
were analyzed using ImageJ. To measure interorigin distances, adja-
cent replication origins within the same fiber were identified, and
then distance in kb was calculated using the conversion factor
1 lm = 2.59 kb [74].
Expanded View for this article is available online.
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